DrugLib.com — Drug Information Portal

Rx drug information, pharmaceutical research, clinical trials, news, and more

Anzemet (Dolasetron Mesylate Monohydrate) - News


News related to Anzemet (Dolasetron) and/or conditions it is approved for

Netupitant/palonosetron for prevention of nausea and vomiting: Added benefit not proven
Source: Cancer / Oncology News From Medical News Today [2015.11.24]
Certain advantages in side effects, but equivalence of main effect has not been proven.

Nausea and Vomiting
Source: MedicineNet Angina Specialty [2014.07.09]
Title: Nausea and Vomiting
Category: Diseases and Conditions
Created: 1/31/2005 8:21:00 AM
Last Editorial Review: 7/9/2014 12:00:00 AM

-- advertisement -- The American Red Cross
Home | About Us | Contact Us | Site usage policy | Privacy policy

All Rights reserved - Copyright DrugLib.com, 2006-2015